// App-Quantinova.ai

TCT577 : Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials

Researchers

Presenter

  • Gennaro Giustino

Principal Investigators

  • Olga Salianski

  • Usman Baber

  • Ghada Mikhail

  • Adnan Kastrati

  • Alaide Chieffo

  • Roxana Mehran

  • Samantha Sartori

  • Melissa Aquino

  • Giulio G. Stefanini

  • Martin Leon

  • Gregg W. Stone

  • Marie-Claude Morice

  • Pieter C. Smits

  • Clemens von Birgelen

Medical Centers

  • Institut Cardiovasculaire Paris Sud, Generale de Sante, Massy, France

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • San Raffael Scientific Institute, Milan, Italy, Milan, Italy

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Icahn School of Medicine at Mount Sinai, Jamaica, NY, United States

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Imperial College, London, United Kingdom

  • Maasstad Hospital Rotterdam, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, New York, United States

  • Thoraxcentrum Twente & University of Twente, Enschede, Netherlands

  • Mount Sinai School of Medicine, New York, NY

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Humanitas Research Hospital-IRCCS, Rozzano (Milan), Italy

Locations

  • Italy

  • Netherlands

  • Germany

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Atherothrombosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved